Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1

Phase 1

Completed

• Conditions: Cocaine-Related Disorders

• Registration Number: NCT00067535
• Lead Sponsor: National Institute on Drug Abuse (NIDA)

Brief Summary

The purpose of this study is to assess Potential Interactions Between iv Cocaine and RPR 102681

Detailed Description

Phase I, Double-Blind, Placebo-Controlled Dose Escalating Assessment of Potential Interactions Between Intravenous Cocaine and RPR 102681

Study Timeline

• Study Start: 2003-06
• Study First Submitted: 2003-08-21
• Study First Submitted QC: 2003-08-22
• Study First Posted: 2003-08-25
• Primary Completion: 2005-01
• Study Completion: 2005-06
• Status Verified: 2009-02
• Last Update Submitted: 2017-01-11
• Last Update Posted: 2017-01-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

Includes but is not limited to:

• Non-treatment seekers
• DSM-IV criteria for cocaine abuse or dependence
• Ability to verbalize understanding of consent form and provide written informed consent and verbalize willingness to complete study procedures; be able to comply with protocol requirements

Exclusion Criteria

Please contact site for more information.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Hemodynamic response to cocaine and subjective response to cocaine	3x / 30 days

Trial Locations

Locations (1)

Uniformed Services University of Health Science; 🇺🇸 Bethesda, Maryland, United States